
NATURE . COM {
}
Title:
Reversibility and recurrence of IGF-IR-induced mammary tumors | Oncogene
Description:
The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {π}
- Education
- Health & Fitness
- Science
Content Management System {π}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of nature.com audience?
π Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {πΈ}
Display Ads {π―}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {π°}
Display Ads {π―}
$63,100 per month
Our analysis indicates Nature.com generates between $42,042 and $115,616 monthly online from display ads.
Keywords {π}
cancer, article, google, scholar, cas, growth, breast, insulinlike, receptor, factor, res, nature, oncogene, mammary, tumor, human, igfir, access, tumors, expression, cell, content, research, cookies, recurrence, jones, campbell, moorehead, transgenic, privacy, function, signaling, mouse, epithelial, transition, open, nat, type, monoclonal, antibody, pubmed, tumorigenesis, moody, ontario, data, petrik, targeting, development, model, transcriptional,
Topics {βοΈ}
nature portfolio permissions reprints privacy policy nature formalin-fixed paraffin-embedded tissues cancer research society tgf-beta-induced collagen expression c-myc-induced mammary adenocarcinomas advertising igf-ir-induced mammary tumors social media health research p19arf/p53 pathway lesions author information authors mammary gland development anti-igf-ir therapies real-time pcr primer conditional wnt-induced tumorigenesis targeting igf-ir author correspondence tumor-size-dependent regression endocrine-responsive breast cancer springerlink instant access personal data recombinant humanized anti-insulin tumor development igf-ir-independent mechanisms signal transduction function regulates epithelial plasticity data protection permissions invasive breast cancers transgenic mouse model igf-ir-dependent e-cadherin gene expression accelerates mammary tumorigenesis breast cancer cells kinase activity human breast cancer igf-ir dependence igf-ir independence human lung tumors igf-ir signaling igf-ir results growth factor receptor breast cancer panagiotis induces tumor formation metastasizing mammary carcinomas igf-ii mrna privacy
Questions {β}
- Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Reversibility and recurrence of IGF-IR-induced mammary tumors
description:The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
datePublished:2009-04-20T00:00:00Z
dateModified:2009-04-20T00:00:00Z
pageStart:2152
pageEnd:2162
sameAs:https://doi.org/10.1038/onc.2009.79
keywords:
insulin-like growth factor
mammary tumorigenesis
tumor recurrence
epithelial to mesenchymal transition
tumor dormancy
Medicine/Public Health
general
Internal Medicine
Cell Biology
Human Genetics
Oncology
Apoptosis
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig6_HTML.jpg
isPartOf:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Reversibility and recurrence of IGF-IR-induced mammary tumors
description:The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
datePublished:2009-04-20T00:00:00Z
dateModified:2009-04-20T00:00:00Z
pageStart:2152
pageEnd:2162
sameAs:https://doi.org/10.1038/onc.2009.79
keywords:
insulin-like growth factor
mammary tumorigenesis
tumor recurrence
epithelial to mesenchymal transition
tumor dormancy
Medicine/Public Health
general
Internal Medicine
Cell Biology
Human Genetics
Oncology
Apoptosis
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig6_HTML.jpg
isPartOf:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {π}(127)
- Earnings of https://link.springer.com/article/10.1038/onc.2009.79?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle
- Profit of https://doi.org/10.1038%2Fnrc2256
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Models%2C%20mechanisms%20and%20clinical%20evidence%20for%20cancer%20dormancy&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2256&volume=7&pages=834-846&publication_year=2007&author=Aguirre-Ghiso%2CJA
- Monthly income for https://doi.org/10.1038%2Fnrc721
- http://scholar.google.com/scholar_lookup?&title=Endocrine-responsive%20breast%20cancer%20and%20strategies%20for%20combating%20resistance&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc721&volume=2&pages=101-112&publication_year=2002&author=Ali%2CS&author=Coombes%2CRC's total income per month
- How much profit is https://doi.org/10.1172%2FJCI114315 making per month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Blockade%20of%20the%20type%20I%20somatomedin%20receptor%20inhibits%20growth%20of%20human%20breast%20cancer%20cells%20in%20athymic%20mice&journal=J%20Clin%20Invest&doi=10.1172%2FJCI114315&volume=84&pages=1418-1423&publication_year=1989&author=Arteaga%2CC&author=Kitten%2CK&author=Coronado%2CE generate?
- How much does https://doi.org/10.1038%2Fbjc.1995.484 net monthly?
- Get to know http://scholar.google.com/scholar_lookup?&title=Mammary%20cancer%20in%20transgenic%20mice%20expressing%20insulin-like%20growth%20factor%20II%20%28IGF-II%29&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.1995.484&volume=72&pages=1189-1193&publication_year=1995&author=Bates%2CP&author=Fisher%2CR&author=Ward%2CA&author=Richardson%2CL&author=Hill%2CDJ&author=Graham%2CCF's earnings
- What's the total monthly financial gain of https://doi.org/10.1016%2Fj.ccr.2004.10.013?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Lack%20of%20sustained%20regression%20of%20c-MYC-induced%20mammary%20adenocarcinomas%20following%20brief%20or%20prolonged%20MYC%20inactivation&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2004.10.013&volume=6&pages=577-586&publication_year=2004&author=Boxer%2CRB&author=Jang%2CJW&author=Sintasath%2CL&author=Chodosh%2CLA
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14695208?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=A%20fully%20human%20monoclonal%20antibody%20to%20the%20insulin-like%20growth%20factor%20I%20receptor%20blocks%20ligand-dependent%20signaling%20and%20inhibits%20human%20tumor%20growth%20in%20vivo&journal=Cancer%20Res&volume=63&pages=8912-8921&publication_year=2003&author=Burtrum%2CD&author=Zhu%2CZ&author=Lu%2CD&author=Anderson%2CDM&author=Prewett%2CM&author=Pereira%2CDS
- How much profit does https://doi.org/10.1158%2F0008-5472.CAN-04-4602 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor%20development%20by%20transgenic%20expression%20of%20a%20constitutively%20active%20insulin-like%20growth%20factor%20I%20receptor&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-04-4602&volume=65&pages=3781-3787&publication_year=2005&author=Carboni%2CJM&author=Lee%2CAV&author=Hadsell%2CDL&author=Rowley%2CBR&author=Lee%2CFY&author=Bol%2CDK pull in?
- See how much https://doi.org/10.1158%2F0008-5472.CAN-06-2044 makes per month
- How much profit is http://scholar.google.com/scholar_lookup?&title=Mesenchymal-to-epithelial%20transition%20facilitates%20bladder%20cancer%20metastasis%3A%20role%20of%20fibroblast%20growth%20factor%20receptor-2&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-2044&volume=66&pages=11271-11278&publication_year=2006&author=Chaffer%2CCL&author=Brennan%2CJP&author=Slavin%2CJL&author=Blick%2CT&author=Thompson%2CEW&author=Williams%2CED making per month?
- Get to know https://doi.org/10.1038%2Fsj.cgt.7700126's earnings
- How much money does http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20human%20breast%20cancer%20cells%20with%20antisense%20RNA%20to%20the%20type%20I%20insulin-like%20growth%20factor%20receptor%20inhibits%20cell%20growth%2C%20suppresses%20tumorigenesis%2C%20alters%20the%20metastatic%20potential%2C%20and%20prolongs%20survival%20in%20vivo&journal=Cancer%20Gene%20Ther&doi=10.1038%2Fsj.cgt.7700126&volume=7&pages=384-395&publication_year=2000&author=Chernicky%2CCL&author=Yi%2CL&author=Tan%2CH&author=Gan%2CSU&author=Ilan%2CJ generate?
- How much does https://doi.org/10.1038%2F84691 pull in?
- How much does http://scholar.google.com/scholar_lookup?&title=c-MYC%20induces%20mammary%20tumorigenesis%20by%20means%20of%20a%20preferred%20pathway%20involving%20spontaneous%20Kras2%20mutations&journal=Nat%20Med&doi=10.1038%2F84691&volume=7&pages=235-239&publication_year=2001&author=D%E2%80%99Cruz%2CCM&author=Gunther%2CEJ&author=Boxer%2CRB&author=Hartman%2CJL&author=Sintasath%2CL&author=Moody%2CSE earn?
- How much revenue does https://doi.org/10.1172%2FJCI33320 produce monthly?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Tumor%20escape%20in%20a%20Wnt1-dependent%20mouse%20breast%20cancer%20model%20is%20enabled%20by%20p19Arf%2Fp53%20pathway%20lesions%20but%20not%20p16%20Ink4a%20loss&journal=J%20Clin%20Invest&doi=10.1172%2FJCI33320&volume=118&pages=51-63&publication_year=2008&author=Debies%2CMT&author=Gestl%2CSA&author=Mathers%2CJL&author=Mikse%2COR&author=Leonard%2CTL&author=Moody%2CSE
- How much does https://link.springer.com/doi/10.1007/s10549-006-9168-1 earn?
- How much profit does http://scholar.google.com/scholar_lookup?&title=The%20growth%20hormone%20receptor%20antagonist%20pegvisomant%20blocks%20both%20mammary%20gland%20development%20and%20MCF-7%20breast%20cancer%20xenograft%20growth&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-006-9168-1&volume=98&pages=315-327&publication_year=2006&author=Divisova%2CJ&author=Kuiatse%2CI&author=Lazard%2CZ&author=Weiss%2CH&author=Vreeland%2CF&author=Hadsell%2CDL make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9699666 generate monthly?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=A%20dominant%20negative%20mutant%20of%20the%20insulin-like%20growth%20factor-I%20receptor%20inhibits%20the%20adhesion%2C%20invasion%20and%20metastasis%20of%20breast%20cancer&journal=Cancer%20Res&volume=58&pages=3353-3361&publication_year=1998&author=Dunn%2CSE&author=Ehrlich%2CM&author=Sharp%2CNJ&author=Keiss%2CK&author=Solomon%2CG&author=Hawkins%2CR is on a monthly basis
- What are the earnings of https://doi.org/10.1038%2Fsj.onc.1208429?
- How much does http://scholar.google.com/scholar_lookup?&title=DeltaEF1%20is%20a%20transcriptional%20repressor%20of%20E-cadherin%20and%20regulates%20epithelial%20plasticity%20in%20breast%20cancer%20cells&journal=Oncogene&doi=10.1038%2Fsj.onc.1208429&volume=24&pages=2375-2385&publication_year=2005&author=Eger%2CA&author=Aigner%2CK&author=Sonderegger%2CS&author=Dampier%2CB&author=Oehler%2CS&author=Schreiber%2CM gross monthly?
- What's https://doi.org/10.1158%2F1535-7163.MCT-05-0252's gross income?
- What's http://scholar.google.com/scholar_lookup?&title=Novel%20human%20monoclonal%20antibodies%20to%20insulin-like%20growth%20factor%20%28IGF%29-II%20that%20potently%20inhibit%20the%20IGF%20receptor%20type%20I%20signal%20transduction%20function&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-05-0252&volume=5&pages=114-120&publication_year=2006&author=Feng%2CY&author=Zhu%2CZ&author=Xiao%2CX&author=Choudhry%2CV&author=Barrett%2CJC&author=Dimitrov%2CDS's gross income?
- Get to know what's the income of https://link.springer.com/doi/10.1007/BF01807035
- How much money does http://scholar.google.com/scholar_lookup?&title=IGF-II%20mRNA%20and%20protein%20are%20expressed%20in%20the%20stroma%20of%20invasive%20breast%20cancers%3A%20an%20in%20situ%20hybridization%20and%20immunohistochemistry%20study&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2FBF01807035&volume=41&pages=43-50&publication_year=1996&author=Giani%2CC&author=Cullen%2CKJ&author=Campani%2CD&author=Rasmussen%2CA generate?
- What's the profit of https://doi.org/10.1002%2Fijc.20543?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=A%20recombinant%20humanized%20anti-insulin-like%20growth%20factor%20receptor%20type%20I%20antibody%20%28h7C10%29%20enhances%20the%20antitumor%20activity%20of%20vinorelbine%20and%20anti-epidermal%20growth%20factor%20receptor%20therapy%20against%20human%20cancer%20xenografts&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.20543&volume=113&pages=316-328&publication_year=2005&author=Goetsch%2CL&author=Gonzalez%2CA&author=Leger%2CO&author=Beck%2CA&author=Pauwels%2CPJ&author=Haeuw%2CJF?
- Discover the revenue of https://doi.org/10.1101%2Fgad.1051603
- How much does http://scholar.google.com/scholar_lookup?&title=Impact%20of%20p53%20loss%20on%20reversal%20and%20recurrence%20of%20conditional%20Wnt-induced%20tumorigenesis&journal=Genes%20Dev&doi=10.1101%2Fgad.1051603&volume=17&pages=488-501&publication_year=2003&author=Gunther%2CEJ&author=Moody%2CSE&author=Belka%2CGK&author=Hahn%2CKT&author=Innocent%2CN&author=Dugan%2CKD rake in every month?
- What is the earnings of https://doi.org/10.1038%2Fsj.onc.1203386?
- What's http://scholar.google.com/scholar_lookup?&title=Cooperative%20interaction%20between%20mutant%20p53%20and%20des%281-3%29IGF-I%20accelerates%20mammary%20tumorigenesis&journal=Oncogene&doi=10.1038%2Fsj.onc.1203386&volume=19&pages=889-898&publication_year=2000&author=Hadsell%2CDL&author=Murphy%2CKL&author=Bonnette%2CSG&author=Reece%2CN&author=Laucirica%2CR&author=Rosen%2CJM's gross income?
- How much cash flow does https://doi.org/10.1158%2F1078-0432.CCR-07-1118 have monthly?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Phase%20I%20dose%20escalation%20study%20of%20the%20anti%20insulin-like%20growth%20factor-I%20receptor%20monoclonal%20antibody%20CP-751%2C871%20in%20patients%20with%20refractory%20solid%20tumors&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1118&volume=13&pages=5834-5840&publication_year=2007&author=Haluska%2CP&author=Shaw%2CHM&author=Batzel%2CGN&author=Yin%2CD&author=Molina%2CJR&author=Molife%2CLR?
- How much revenue does https://doi.org/10.1016%2FS0140-6736%2897%2910384-1 generate?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Circulating%20concentrations%20of%20insulin-like%20growth%20factor-I%20and%20risk%20of%20breast%20cancer&journal=Lancet&doi=10.1016%2FS0140-6736%2897%2910384-1&volume=351&pages=1393-1396&publication_year=1998&author=Hankinson%2CSE&author=Willett%2CWC&author=Colditz%2CGA&author=Hunter%2CDJ&author=Michaud%2CDS&author=Deroo%2CB generate?
- How much revenue does https://doi.org/10.1056%2FNEJMra043186 generate?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Trastuzumab%E2%80%94mechanism%20of%20action%20and%20use%20in%20clinical%20practice&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMra043186&volume=357&pages=39-51&publication_year=2007&author=Hudis%2CCA?
- What's the revenue for https://doi.org/10.1002%2Fjcp.21223?
- http://scholar.google.com/scholar_lookup?&title=Epithelial-mesenchymal%20and%20mesenchymal-epithelial%20transitions%20in%20carcinoma%20progression&journal=J%20Cell%20Physiol&doi=10.1002%2Fjcp.21223&volume=213&pages=374-383&publication_year=2007&author=Hugo%2CH&author=Ackland%2CML&author=Blick%2CT&author=Lawrence%2CMG&author=Clements%2CJA&author=Williams%2CED's revenue stream
- Learn how profitable https://doi.org/10.1038%2Fsj.onc.1209955 is on a monthly basis
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Transgenic%20overexpression%20of%20IGF-IR%20disrupts%20mammary%20ductal%20morphogenesis%20and%20induces%20tumor%20formation&journal=Oncogene&doi=10.1038%2Fsj.onc.1209955&volume=26&pages=1636-1644&publication_year=2007&author=Jones%2CRA&author=Campbell%2CCI&author=Gunther%2CEJ&author=Chodosh%2CLA&author=Petrik%2CJJ&author=Khokha%2CR?
- What's the income generated by https://doi.org/10.1158%2F1541-7786.MCR-07-2157 each month?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Characterization%20of%20a%20novel%20primary%20mammary%20tumor%20cell%20line%20reveals%20that%20cyclin%20D1%20is%20regulated%20by%20the%20type%20I%20insulin-like%20growth%20factor%20receptor&journal=Mol%20Cancer%20Res&doi=10.1158%2F1541-7786.MCR-07-2157&volume=6&pages=819-828&publication_year=2008&author=Jones%2CRA&author=Campbell%2CCI&author=Petrik%2CJJ&author=Moorehead%2CRA
- What's the monthly income of https://doi.org/10.1073%2Fpnas.0611192104?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=MicroRNA-192%20in%20diabetic%20kidney%20glomeruli%20and%20its%20function%20in%20TGF-beta-induced%20collagen%20expression%20via%20inhibition%20of%20E-box%20repressors&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0611192104&volume=104&pages=3432-3437&publication_year=2007&author=Kato%2CM&author=Zhang%2CJ&author=Wang%2CM&author=Lanting%2CL&author=Yuan%2CH&author=Rossi%2CJJ generate?
- What's the financial outcome of https://doi.org/10.2325%2Fjbcs.954?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Current%20clinical%20trials%20of%20endocrine%20therapy%20for%20breast%20cancer&journal=Breast%20Cancer&doi=10.2325%2Fjbcs.954&volume=14&pages=200-214&publication_year=2007&author=Kurebayashi%2CJ generate?
- How much profit is https://doi.org/10.1016%2FS0304-3835%2803%2900159-9 making per month?
- How much profit does http://scholar.google.com/scholar_lookup?&title=The%20insulin-like%20growth%20factor%20system%20and%20cancer&journal=Cancer%20Lett&doi=10.1016%2FS0304-3835%2803%2900159-9&volume=195&pages=127-137&publication_year=2003&author=LeRoith%2CD&author=Roberts%2CCT generate?
- Financial intake of https://doi.org/10.1002%2Fijc.20814
- How much income does http://scholar.google.com/scholar_lookup?&title=Use%20of%20a%20transgenic%20mouse%20model%20to%20identify%20markers%20of%20human%20lung%20tumors&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.20814&volume=114&pages=977-982&publication_year=2005&author=Linnerth%2CNM&author=Sirbovan%2CK&author=Moorehead%2CRA have?
- Get to know https://doi.org/10.1093%2Fjnci%2F93.24.1852's earnings
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor-I%20receptor%20signaling%20and%20resistance%20to%20trastuzumab%20%28Herceptin%29&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F93.24.1852&volume=93&pages=1852-1857&publication_year=2001&author=Lu%2CY&author=Zi%2CX&author=Zhao%2CY&author=Mascarenhas%2CD&author=Pollak%2CM?
- What's the monthly income of https://doi.org/10.1016%2FS1535-6108%2804%2900050-9?
- How much does http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20the%20insulin-like%20growth%20factor%20receptor-1%20tyrosine%20kinase%20activity%20as%20a%20therapeutic%20strategy%20for%20multiple%20myeloma%2C%20other%20hematologic%20malignancies%2C%20and%20solid%20tumors&journal=Cancer%20Cell&doi=10.1016%2FS1535-6108%2804%2900050-9&volume=5&pages=221-230&publication_year=2004&author=Mitsiades%2CCS&author=Mitsiades%2CNS&author=McMullan%2CCJ&author=Poulaki%2CV&author=Shringarpure%2CR&author=Akiyama%2CM net monthly?
- How much revenue does https://doi.org/10.1016%2Fj.ccr.2005.07.009 produce monthly?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=The%20transcriptional%20repressor%20Snail%20promotes%20mammary%20tumor%20recurrence&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2005.07.009&volume=8&pages=197-209&publication_year=2005&author=Moody%2CSE&author=Perez%2CD&author=Pan%2CTC&author=Sarkisian%2CCJ&author=Portocarrero%2CCP&author=Sterner%2CCJ
- What's the income of https://doi.org/10.1016%2FS1535-6108%2802%2900212-X?
- Profit of http://scholar.google.com/scholar_lookup?&title=Conditional%20activation%20of%20Neu%20in%20the%20mammary%20epithelium%20of%20transgenic%20mice%20results%20in%20reversible%20pulmonary%20metastasis&journal=Cancer%20Cell&doi=10.1016%2FS1535-6108%2802%2900212-X&volume=2&pages=451-461&publication_year=2002&author=Moody%2CSE&author=Sarkisian%2CCJ&author=Hahn%2CKT&author=Gunther%2CEJ&author=Pickup%2CS&author=Dugan%2CKD
- https://doi.org/10.1038%2Fsj.onc.1210379's revenue stream
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Trastuzumab%3A%20triumphs%20and%20tribulations&journal=Oncogene&doi=10.1038%2Fsj.onc.1210379&volume=26&pages=3637-3643&publication_year=2007&author=Nahta%2CR&author=Esteva%2CFJ?
- What's the profit of https://doi.org/10.1016%2Fj.bcp.2007.10.032?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20cytochrome%20P450%202A5%20in%20a%20glucose-6-phosphate%20dehydrogenase-deficient%20mouse%20model%20of%20oxidative%20stress&journal=Biochem%20Pharmacol&doi=10.1016%2Fj.bcp.2007.10.032&volume=75&pages=1230-1239&publication_year=2008&author=Nichols%2CKD&author=Kirby%2CGM?
- How much income is https://link.springer.com/doi/10.1007/BF01833331 earning monthly?
- See how much http://scholar.google.com/scholar_lookup?&title=Expression%20of%20IGF-I%20and%20IGF-II%20mRNA%20in%20breast%20tissue&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2FBF01833331&volume=22&pages=31-38&publication_year=1992&author=Paik%2CS makes per month
- What's the financial intake of https://doi.org/10.1038%2Fsj.bjc.6690112?
- How much does http://scholar.google.com/scholar_lookup?&title=Altered%20expression%20of%20the%20IGF-1%20receptor%20in%20a%20tamoxifen-resistant%20human%20breast%20cancer%20cell%20line&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6690112&volume=79&pages=693-700&publication_year=1999&author=Parisot%2CJP&author=Hu%2CXF&author=DeLuise%2CM&author=Zalcberg%2CJR earn?
- Revenue of https://doi.org/10.1093%2Fnar%2Fgkj155
- Earnings of http://scholar.google.com/scholar_lookup?&title=RTPrimerDB%3A%20the%20real-time%20PCR%20primer%20and%20probe%20database%2C%20major%20update%202006&journal=Nucleic%20Acids%20Res&doi=10.1093%2Fnar%2Fgkj155&volume=34&pages=D684-D688&publication_year=2006&author=Pattyn%2CF&author=Robbrecht%2CP&author=De%2CPA&author=Speleman%2CF&author=Vandesompele%2CJ
- How much income is https://doi.org/10.1038%2Fnrc2131 earning monthly?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Snail%2C%20Zeb%20and%20bHLH%20factors%20in%20tumour%20progression%3A%20an%20alliance%20against%20the%20epithelial%20phenotype%3F&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2131&volume=7&pages=415-428&publication_year=2007&author=Peinado%2CH&author=Olmeda%2CD&author=Cano%2CA?
- How much does https://doi.org/10.1073%2Fpnas.0801197105 bring in each month?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Oncogene%20cooperation%20in%20tumor%20maintenance%20and%20tumor%20recurrence%20in%20mouse%20mammary%20tumors%20induced%20by%20Myc%20and%20mutant%20Kras&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0801197105&volume=105&pages=5242-5247&publication_year=2008&author=Podsypanina%2CK&author=Politi%2CK&author=Beverly%2CLJ&author=Varmus%2CHE
- How much does https://doi.org/10.1038%2Fnrc1387 make?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factors%20and%20neoplasia&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc1387&volume=4&pages=505-518&publication_year=2004&author=Pollak%2CMN&author=Schernhammer%2CES&author=Hankinson%2CSE?
- How much does https://doi.org/10.1002%2F%28SICI%291097-010X%2819980501%29281%3A1%3C43%3A%3AAID-JEZ7%3E3.0.CO%3B2-C gross monthly?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Metastasizing%20mammary%20carcinomas%20in%20H19%20enhancers-Igf2%20transgenic%20mice&journal=J%20Exp%20Zool&doi=10.1002%2F%28SICI%291097-010X%2819980501%29281%3A1%3C43%3A%3AAID-JEZ7%3E3.0.CO%3B2-C&volume=281&pages=43-57&publication_year=1998&author=Pravtcheva%2CDD&author=Wise%2CTL?
- What is the monthly revenue of https://doi.org/10.1016%2FS0140-6736%2804%2916044-3?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%20%28IGF%29-I%2C%20IGF%20binding%20protein-3%2C%20and%20cancer%20risk%3A%20systematic%20review%20and%20meta-regression%20analysis&journal=Lancet&doi=10.1016%2FS0140-6736%2804%2916044-3&volume=363&pages=1346-1353&publication_year=2004&author=Renehan%2CAG&author=Zwahlen%2CM&author=Minder%2CC&author=O%E2%80%99Dwyer%2CST&author=Shalet%2CSM&author=Egger%2CM
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9515800's revenue stream
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Elevated%20insulin-like%20growth%20factor%20I%20receptor%20autophosphorylation%20and%20kinase%20activity%20in%20human%20breast%20cancer&journal=Cancer%20Res&volume=58&pages=1159-1164&publication_year=1998&author=Resnik%2CJL&author=Reichart%2CDB&author=Huey%2CK&author=Webster%2CNJG&author=Seely%2CBL
- What's the income of https://doi.org/10.1158%2F1078-0432.CCR-07-1109?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=IMC-A12%2C%20a%20human%20IgG1%20monoclonal%20antibody%20to%20the%20insulin-like%20growth%20factor%20I%20receptor&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1109&volume=13&pages=5549s-5555s&publication_year=2007&author=Rowinsky%2CEK&author=Youssoufian%2CH&author=Tonra%2CJR&author=Solomon%2CP&author=Burtrum%2CD&author=Ludwig%2CDL?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7757999 generate?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Malignant%20breast%20epithelium%20selects%20for%20insulin-like%20growth%20factor%20II%20expression%20in%20breast%20stroma%3A%20evidence%20for%20paracrine%20function&journal=Cancer%20Res&volume=55&pages=2448-2454&publication_year=1995&author=Singer%2CC&author=Rasmussen%2CA&author=Smith%2CHS&author=Lippman%2CME&author=Lynch%2CHT&author=Cullen%2CKJ?
- Revenue of https://doi.org/10.1056%2FNEJM200103153441101
- How profitable is http://scholar.google.com/scholar_lookup?&title=Use%20of%20chemotherapy%20plus%20a%20monoclonal%20antibody%20against%20HER2%20for%20metastatic%20breast%20cancer%20that%20overexpresses%20HER2&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJM200103153441101&volume=344&pages=783-792&publication_year=2001&author=Slamon%2CDJ&author=Leyland-Jones%2CB&author=Shak%2CS&author=Fuchs%2CH&author=Paton%2CV&author=Bajamonde%2CA?
- Explore the financials of https://doi.org/10.1023%2FA%3A1009523501499
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Function%20of%20the%20IGF-I%20receptor%20in%20breast%20cancer&journal=J%20Mam%20Gland%20Biol%20Neoplasia&doi=10.1023%2FA%3A1009523501499&volume=5&pages=95-105&publication_year=2000&author=Surmacz%2CE each month?
- How much profit does https://doi.org/10.1016%2Fj.bbrc.2007.11.151 make?
- See how much http://scholar.google.com/scholar_lookup?&title=Twist%20is%20a%20transcriptional%20repressor%20of%20E-cadherin%20gene%20expression%20in%20breast%20cancer&journal=Biochem%20Biophys%20Res%20Commun&doi=10.1016%2Fj.bbrc.2007.11.151&volume=367&pages=235-241&publication_year=2008&author=Vesuna%2CF&author=van%2CDP&author=Chen%2CJH&author=Raman%2CV makes per month
- https://doi.org/10.1016%2Fj.cell.2004.06.006's revenue stream
- Find out how much http://scholar.google.com/scholar_lookup?&title=Twist%2C%20a%20master%20regulator%20of%20morphogenesis%2C%20plays%20an%20essential%20role%20in%20tumor%20metastasis&journal=Cell&doi=10.1016%2Fj.cell.2004.06.006&volume=117&pages=927-939&publication_year=2004&author=Yang%2CJ&author=Mani%2CSA&author=Donaher%2CJL&author=Ramaswamy%2CS&author=Itzykson%2CRA&author=Come%2CC earns monthly
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3180080?
- How much does http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%20II%20mRNA%20expression%20in%20human%20breast%20cancer&journal=Cancer%20Res&volume=48&pages=6691-6696&publication_year=1988&author=Yee%2CD&author=Cullen%2CKJ&author=Paik%2CS&author=Perdue%2CJF&author=Hampton%2CB&author=Schwartz%2CA earn?
- What is the monthly revenue of https://doi.org/10.1210%2Fmend-3-3-509?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20insulin-like%20growth%20factor%20I%20gene%20expression%20in%20malignancy%3A%20evidence%20for%20a%20paracrine%20role%20in%20human%20breast%20cancer&journal=Mol%20Endocrinol&doi=10.1210%2Fmend-3-3-509&volume=3&pages=509-517&publication_year=1989&author=Yee%2CD&author=Paik%2CS&author=Lebovic%2CGS&author=Marcus%2CRR&author=Favoni%2CRE&author=Cullen%2CKJ
- How profitable is https://citation-needed.springer.com/v2/references/10.1038/onc.2009.79?format=refman&flavour=references?
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R%20A%20Jones?
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R%20A%20Jones%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C%20I%20Campbell?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C%20I%20Campbell%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=G%20A%20Wood bring in each month?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22G%20A%20Wood%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J%20J%20Petrik bring in each month?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J%20J%20Petrik%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R%20A%20Moorehead rake in every month?
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R%20A%20Moorehead%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much income does https://s100.copyright.com/AppDispatchServlet?title=Reversibility%20and%20recurrence%20of%20IGF-IR-induced%20mammary%20tumors&author=R%20A%20Jones%20et%20al&contentID=10.1038%2Fonc.2009.79©right=Macmillan%20Publishers%20Limited&publication=0950-9232&publicationDate=2009-04-20&publisherName=SpringerNature&orderBeanReset=true have?
- How much revenue does https://citation-needed.springer.com/v2/references/10.1038/onc.2009.79?format=refman&flavour=citation bring in?
- https://doi.org/10.1038/s41388-018-0362-5's revenue stream
- How much does https://doi.org/10.1186/s12943-015-0291-7 generate monthly?
- https://doi.org/10.1038/onc.2013.373's financial summary
- What's the total monthly financial gain of https://doi.org/10.1038/onc.2012.4?
- What's the monthly income of https://doi.org/10.1007/s12282-011-0299-9?
- Learn about the earnings of https://www.protocols.io/
- How much money does https://www.natureindex.com/ generate?
- How much income does http://www.naturechina.com have?
- How much cash flow does https://www.natureasia.com/ja-jp have monthly?
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Prism.js
- Zoom.js
Emails and Hosting {βοΈ}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {π¦}
- Crossref